Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy
Background Adoptive transfer of patient’s T cells, engineered to express a T cell receptor (TCR) with defined novel antigen specificity, is a convenient form of cancer therapy. In most cases, major histocompatibility complex (MHC) I-restricted TCRs are expressed in CD8+ T cells and the development o...
Main Authors: | Thomas Blankenstein, Natalia Plewa, Lucia Poncette |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-02-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/2/e006001.full |
Similar Items
-
P1254: BASELINE HLA-DR-RESTRICTED NEOANTIGEN BURDEN OF AML BLASTS IMPACTS ON HLA-DR GENE EXPRESSION AT RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT
by: Sarah Charrot, et al.
Published: (2023-08-01) -
Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
by: Susumu Iiizumi, et al.
Published: (2019-02-01) -
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
by: Belén Aparicio, et al.
Published: (2022-11-01) -
Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires
by: Corinna Grunert, et al.
Published: (2022-04-01) -
Identification of HLA-A2-Restricted Mutant Epitopes from Neoantigens of Esophageal Squamous Cell Carcinoma
by: Zhiwei Wang, et al.
Published: (2021-10-01)